Anti-Spike SARS-CoV-2 IgG Assessment with a Commercial Assay during a 4-Month Course after COVID-19 Vaccination

Código QR

Anti-Spike SARS-CoV-2 IgG Assessment with a Commercial Assay during a 4-Month Course after COVID-19 Vaccination

We intended to assess the humoral response induced by the Pfizer/BioNTech Comirnaty COVID-19 vaccine with commercially available immunoassays: anti-spike (S) IgG and IgM, and anti-nucleocapsid (N) IgG antibodies, over a 4-month course. One hundred subjects, including 15 COVID-19 convalescents, compr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jakub Swadźba, Tomasz Anyszek, Andrzej Panek, Emilia Martin
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	SARS-CoV-2 antibodies COVID-19 testing COVID-19 vaccines COVID-19 vaccines booster shot Medicine R
Acceso en línea:	https://doaj.org/article/81d9d99ff95c4f208db17f815b29de2e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination
por: Bettina Experton, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy and Attitude toward Booster Doses among US Healthcare Workers
por: Suman Pal, et al.
Publicado: (2021)

COVID-19 Delta Variant: Perceptions, Worries, and Vaccine-Booster Acceptability among Healthcare Workers
por: Khalid Alhasan, et al.
Publicado: (2021)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
por: Piotr Rzymski, et al.
Publicado: (2021)

The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia
por: Rivaldo Steven Heriyanto, et al.
Publicado: (2021)

Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ)
por: Juan Luis Delgado-Gallegos, et al.
Publicado: (2021)

Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns
por: Matteo Nioi, et al.
Publicado: (2021)

Lymphadenopathy after the third Covid-19 vaccine
por: Can Özütemiz, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study
por: Jian Wu, et al.
Publicado: (2021)

Prevalence and Factors Associated with Parents’ Non-Intention to Vaccinate Their Children and Adolescents against COVID-19 in Latin America and the Caribbean
por: Diego Urrunaga-Pastor, et al.
Publicado: (2021)

COVID-19 Vaccine Acceptance among Liver Transplant Recipients
por: Andrea Costantino, et al.
Publicado: (2021)

Anti-COVID Vaccination for Adolescents: A Survey on Determinants of Vaccine Parental Hesitancy
por: Stefano Zona, et al.
Publicado: (2021)

The Waiver of Patent Protections for COVID-19 Vaccines During the Ongoing Pandemic and the Conspiracy Theories: Lights and Shadows of an Issue on the Ground
por: Matteo Nioi, et al.
Publicado: (2021)

SARS-CoV-2 immunity and an overview of the COVID-19 vaccines
por: Marković Miloš
Publicado: (2021)

COVID-19 Vaccine Hesitancy among Italian University Students: A Cross-Sectional Survey during the First Months of the Vaccination Campaign
por: Valentina Baccolini, et al.
Publicado: (2021)

Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG
por: Jamiruddin MR, et al.
Publicado: (2021)

The Effect of the COVID-19 Vaccine on Daily Cases and Deaths Based on Global Vaccine Data
por: Zhiwei Li, et al.
Publicado: (2021)

Investigating Adherence to COVID-19 Vaccination and Serum Antibody Concentration among Hospital Workers—The Experience of an Italian Private Hospital
por: Guglielmo Forgeschi, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy in Healthcare Personnel: A University Hospital Experience
por: Beril Kara Esen, et al.
Publicado: (2021)

Recommending COVID-19 Vaccines to Patients: Practice and Concerns of Frontline Family Doctors
por: Paul Kwok Ming Poon, et al.
Publicado: (2021)

Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
por: Rami Alqassieh, et al.
Publicado: (2021)

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
por: Robert Flisiak, et al.
Publicado: (2021)

COVID-19 reinfection: the role of natural immunity, vaccines, and variants
por: Bao Y. Sciscent, et al.
Publicado: (2021)

Patients’ Perception and Knowledge about Influenza and Pneumococcal Vaccination during the COVID-19 Pandemic: An Online Survey in Patients at Risk of Infections
por: Paul Loubet, et al.
Publicado: (2021)

Sudden sensorineural hearing loss after COVID-19 vaccination
por: Junhui Jeong, et al.
Publicado: (2021)

Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection
por: Kun Li, et al.
Publicado: (2020)

Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China
por: Liubing Gong, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
por: Martin C. S. Wong, et al.
Publicado: (2021)

Estimating Vaccine Confidence Levels among Healthcare Staff and Students of a Tertiary Institution in South Africa
por: Elizabeth O. Oduwole, et al.
Publicado: (2021)

COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis
por: Clio Bilotta, et al.
Publicado: (2021)

Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review
por: Nuru Saadi, et al.
Publicado: (2021)

Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
por: Mohammadreza Ardalan, et al.
Publicado: (2021)

Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions
por: Sang Won Lee, et al.
Publicado: (2021)

Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study
por: Frank-Peter Tillmann, et al.
Publicado: (2021)

Vaccinating against COVID-19: The Correlation between Pro-Vaccination Attitudes and the Belief That Our Peers Want to Get Vaccinated
por: Darie Cristea, et al.
Publicado: (2021)

The EU Digital COVID Certificate: Should We Differentiate Between Previously Infected and Fully Vaccinated People?
por: José Gonçalo Marques
Publicado: (2021)

Kikuchi–Fujimoto Disease Post COVID-19 Vaccination: Case Report and Review of Literature
por: Hui Min Tan, et al.
Publicado: (2021)

Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics
por: Madison Crutcher, et al.
Publicado: (2021)

COVID-19 and SARS-CoV-2: Everything we know so far – A comprehensive review
por: Naz Sumaira, et al.
Publicado: (2021)

Comparing the Attitude toward the COVID-19 and the 2020/21 and 2019/20 Flu Vaccination Campaigns among Italian Healthcare Workers
por: Giulia Collatuzzo, et al.
Publicado: (2021)